Symptomatic children may have pulmonary embolism and/or deep vein thrombosis at similar rates to adults, despite current literature.

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Suppressing REM sleep with antidepressants may increase survival in patients with amyotrophic lateral sclerosis.

The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.